Cure SMA Revenue and Competitors

Claim your profile

Chicago, IL USA

Location

N/A

Total Funding

NonProfit

Industry

Estimated Revenue & Valuation

  • Cure SMA's estimated annual revenue is currently $7.5M per year.(i)
  • Cure SMA's estimated revenue per employee is $82,418

Employee Data

  • Cure SMA has 91 Employees.(i)
  • Cure SMA grew their employee count by 15% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15M183-3%N/AN/A
#2
$35M95-19%N/AN/A
#3
$3.5M3517%N/AN/A
#4
$15M3815%N/AN/A
#5
$3.5M86N/AN/AN/A
#6
$3.5M8117%N/AN/A
#7
$3.5M20-17%N/AN/A
#8
$75M8627%N/AN/A
#9
N/A38138%N/AN/A
#10
$3.5M9612%N/AN/A

Cure SMA is dedicated to the treatment and cure of spinal muscular atrophy (SMA)a disease that takes away a person's ability to walk, eat, or breathe. It is the number one genetic cause of death for infants. Since 1984, we've directed and invested in comprehensive research that has shaped the scientific community's understanding of SMA. We are currently on the verge of breakthroughs in treatment that will strengthen our children's bodies, extend life, and lead to a cure. We have deep expertise in every aspect of SMAfrom the day-to-day realities to the nuances of care optionsand until we have a cure, well do everything we can to support children and families affected by the disease. Cure SMA is a non-profit organization which has funded and directed over $75 million for leading SMA research programs. We have 34 Chapters throughout the United States and over 115,000 members and supporters. We also host the world's largest Annual SMA Conference with over 1,500 families and researchers from around the world in attendance. Learn more about how you can help us reach a treatment and cure at www.cureSMA.org.

keywords:Biotechnology,Healthcare,Pharmaceuticals

N/A

Total Funding

91

Number of Employees

$7.5M

Revenue (est)

15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cure SMA News

2022-04-19 - Baby Vihaan needs your support, help him survive SMA: Sonu Sood to people

Zolgensma injection is the only treatment option available to cure SMA and it is impossible for the family to raise such a large sum all by...

2022-04-06 - In India, Parents of Children with Rare Disease Plea for Help Online

In 2019, the U.S. Food and Drug Administration approved the gene therapy Zolgensma, which alters the underlying genetic cause of spinal muscular...

2022-03-22 - Parents of spinal muscular atrophy patients meet Vij

Sushila, who also represents Gurugram-based Cure SMA Foundation of India as its Haryana coordinator, said, “Through our representation,...

2019-09-08 - Cytokinetics and Cure SMA Renew Their Partnership

The biopharmaceutical company Cytokinetics and the nonprofit organization Cure SMA have announced a renewal of their partnership.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$30.2M922%N/A
#2
$21.8M960%N/A
#3
$7.5M9823%N/A
#4
$13.9M1005%N/A
#5
$25.2M103-3%N/A